- Home
- RBKB vs CYBN Comparison
RBKB vs CYBN Comparison
Compare RBKB & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBKB
- CYBN
- Stock Information
- Founded
- RBKB 1860
- CYBN 2019
- Country
- RBKB United States
- CYBN Canada
- Employees
- RBKB N/A
- CYBN N/A
- Industry
- RBKB Banks
- CYBN Pharmaceuticals and Biotechnology
- Sector
- RBKB Finance
- CYBN Health Care
- Exchange
- RBKB Nasdaq
- CYBN Nasdaq
- Market Cap
- RBKB 111.3M
- CYBN 127.3M
- IPO Year
- RBKB 2019
- CYBN N/A
- Fundamental
- Price
- RBKB $11.07
- CYBN $6.55
- Analyst Decision
- RBKB
- CYBN Strong Buy
- Analyst Count
- RBKB 0
- CYBN 4
- Target Price
- RBKB N/A
- CYBN $86.00
- AVG Volume (30 Days)
- RBKB 9.0K
- CYBN 218.9K
- Earning Date
- RBKB 04-24-2025
- CYBN 06-25-2025
- Dividend Yield
- RBKB N/A
- CYBN N/A
- EPS Growth
- RBKB N/A
- CYBN N/A
- EPS
- RBKB N/A
- CYBN N/A
- Revenue
- RBKB $25,911,000.00
- CYBN N/A
- Revenue This Year
- RBKB N/A
- CYBN N/A
- Revenue Next Year
- RBKB N/A
- CYBN N/A
- P/E Ratio
- RBKB N/A
- CYBN N/A
- Revenue Growth
- RBKB N/A
- CYBN N/A
- 52 Week Low
- RBKB $7.30
- CYBN $4.81
- 52 Week High
- RBKB $11.53
- CYBN $14.44
- Technical
- Relative Strength Index (RSI)
- RBKB 62.13
- CYBN 48.77
- Support Level
- RBKB $11.00
- CYBN $6.37
- Resistance Level
- RBKB $11.53
- CYBN $7.29
- Average True Range (ATR)
- RBKB 0.25
- CYBN 0.39
- MACD
- RBKB 0.02
- CYBN 0.02
- Stochastic Oscillator
- RBKB 71.43
- CYBN 50.00
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.